Format

Send to

Choose Destination
Oncotarget. 2014 Jan 30;5(2):309-25.

Apoptosis inducers in chronic lymphocytic leukemia.

Author information

1
INSERM U 872, Centre de Recherche des Cordeliers, Equipe 18, Paris, France.

Abstract

Chronic lymphocytic leukemia (CLL) is characterized by a typical defect in apoptosis and is still an incurable disease. Numerous apoptosis inducers have been described. These synthetic compounds and natural products (mainly derived from plants) display antileukemic properties in vitro and in vivo and some have even been tested in the clinic in CLL. They act through several different mechanisms. Most of them involve proteins of the Bcl-2 family, which are the key regulators in triggering the mitochondrial pathway of caspase-dependent apoptosis. Thus, the Mcl-1/Noxa axis appeared as a target. Here I overview natural and synthetic apoptosis inducers and their mechanisms of action in CLL cells. Opportunities for developing novel, apoptosis-based therapeutics are presented.

PMID:
24525395
PMCID:
PMC3964209
DOI:
10.18632/oncotarget.1480
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center